Prolactin-induced prostate tumorigenesis (Q38282726)

1 September 2017

1 reference

title

Prolactin-induced prostate tumorigenesis (English)

1 reference

1 September 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25472541%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

author name string

Vincent Goffin

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25472541%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

language of work or name

English

0 references

publication date

1 January 2015

1 reference

Advances in Experimental Medicine and Biology

1 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25472541%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

volume

846

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25472541%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

page(s)

221-242

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25472541%20AND%20SRC:MED&resulttype=core&format=json

Prolactin is a survival factor for androgen-deprived rat dorsal and lateral prostate epithelium in organ culture

10 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

PRL signal transduction in the epithelial compartment of rat prostate maintained as long-term organ cultures in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Inhibition of transcription factor Stat5 induces cell death of human prostate cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

The reactive stroma microenvironment and prostate cancer progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Cancer risk in hyperprolactinemia patients: a population-based cohort study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

S179D-human PRL, a pseudophosphorylated human PRL analog, is an agonist and not an antagonist

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Development of pure prolactin receptor antagonists.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Prospective evaluation of AMACR (P504S) and basal cell markers in the assessment of routine prostate needle biopsy specimens

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Adult murine prostate basal and luminal cells are self-sustained lineages that can both serve as targets for prostate cancer initiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Completely humanizing prolactin rescues infertility in prolactin knockout mice and leads to human prolactin expression in extrapituitary mouse tissues

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Prolactin and prostate hypertrophy: a pilot observational, prospective, case-control study in men with prolactinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription-5a/b signaling pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Transcription factor signal transducer and activator of transcription 5 promotes growth of human prostate cancer cells in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Molecular pathways: blockade of the PRLR signaling pathway as a novel antihormonal approach for the treatment of breast and prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Neutralization of prolactin receptor function by monoclonal antibody LFA102, a novel potential therapeutic for the treatment of breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Gene expression analysis of prostate hyperplasia in mice overexpressing the prolactin gene specifically in the prostate

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Endogenous sex hormones and prostate cancer: a quantitative review of prospective studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Response of glandular versus basal rat ventral prostatic epithelial cells to androgen withdrawal and replacement

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Prolactin directly stimulates citrate production and mitochondrial aspartate aminotransferase of prostate epithelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Prospective study of sex hormone levels and risk of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Development and potential clinical uses of human prolactin receptor antagonists

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Drug Insight: prolactin-receptor antagonists, a novel approach to treatment of unresolved systemic and local hyperprolactinemia?

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Prolactin regulation of the prostate gland: a female player in a male game

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Identification of a cell of origin for human prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Primitive origins of prostate cancer: in vivo evidence for prostate-regenerating cells and prostate cancer-initiating cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Transcription factor Stat3 stimulates metastatic behavior of human prostate cancer cells in vivo, whereas Stat5b has a preferential role in the promotion of prostate cancer cell viability and tumor growth.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Activating mutation (V617F) in the tyrosine kinase JAK2 is absent in locally-confined or castration-resistant prostate cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Pharmacologic inhibition of Jak2-Stat5 signaling By Jak2 inhibitor AZD1480 potently suppresses growth of both primary and castrate-resistant prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Pharmacologic suppression of JAK1/2 by JAK1/2 inhibitor AZD1480 potently inhibits IL-6-induced experimental prostate cancer metastases formation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

STAT5A/B gene locus undergoes amplification during human prostate cancer progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Paradigm-shifters: phosphorylated prolactin and short prolactin receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

In vitro characterization of prolactin-induced effects on proliferation in the neoplastic LNCaP, DU145, and PC3 models of the human prostate

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Progressive prostate hyperplasia in adult prolactin transgenic mice is not dependent on elevated serum androgen levels

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Prostate hyperplasia in a transgenic mouse with prostate-specific expression of prolactin.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Signal transducer and activator of transcription 5a/b: biomarker and therapeutic target in prostate and breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Prostatic inflammation enhances basal-to-luminal differentiation and accelerates initiation of prostate cancer with a basal cell origin

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Basal epithelial stem cells are efficient targets for prostate cancer initiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Prolactin receptor expression in the developing human prostate and in hyperplastic, dysplastic, and neoplastic lesions

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Activation of signal transducer and activator of transcription 5 in human prostate cancer is associated with high histological grade

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Activation of signal transducer and activator of transcription-5 in prostate cancer predicts early recurrence

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Transcription factor Stat5a/b as a therapeutic target protein for prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Prolactin specifically regulates citrate oxidation and m-aconitase of rat prostate epithelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Minireview: Extrapituitary prolactin: an update on the distribution, regulation, and functions

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Medical management of prolactin-secreting pituitary adenomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

STAT5b Deficiency: An Unsuspected Cause of Growth Failure, Immunodeficiency, and Severe Pulmonary Disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Estrogen and Prolactin Regulation of Rat Dorsal and Lateral Prostate in Organ Culture*

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Androgen‐dependent expression of prolactin in rat prostate epithelium in vivo and in organ culture

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Prolactin and prolactin receptors are expressed and functioning in human prostate

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Epithelial defect in prostates of Stat5a-null mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Mutant prolactin receptor and familial hyperprolactinemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Cytokine receptor signaling through the Jak-Stat-Socs pathway in disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Alpha emitter radium-223 and survival in metastatic prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Quantification of prolactin receptor mRNA in multiple human tissues and cancer cell lines by real time RT-PCR.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Plasma estradiol, free testosterone, sex hormone binding globulin binding capacity, and prolactin in benign prostatic hyperplasia and prostatic cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Prostate development and carcinogenesis in prolactin receptor knockout mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Local prolactin is a target to prevent expansion of basal/stem cells in prostate tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

The survival effect of prolactin on PC3 prostate cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Abiraterone in metastatic prostate cancer without previous chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Gene expression profiles of ductal versus acinar adenocarcinoma of the prostate

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Measurements of Prolactin and Androgens in Patients with Prostatic Diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Increased survival with enzalutamide in prostate cancer after chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Genome-wide linkage scan for prostate cancer aggressiveness loci using families from the University of Michigan Prostate Cancer Genetics Project

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Plasma prolactin and prostate cancer risk: A prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

The effect of prolactin on human BPH epithelial cell proliferation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Transcription factor Stat5 synergizes with androgen receptor in prostate cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Integrative genomic profiling of human prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Testosterone and prolactin increase carboxypeptidase-D and nitric oxide levels to promote survival of prostate cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Carboxypeptidase-D is elevated in prostate cancer and its anti-apoptotic activity is abolished by combined androgen and prolactin receptor targeting

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Human prolactin receptors are insensitive to mouse prolactin: implications for xenotransplant modeling of human breast cancer in mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Insensitivity of human prolactin receptors to nonhuman prolactins: relevance for experimental modeling of prolactin receptor-expressing human cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Mouse models of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Effects of hyperprolactinemia on rat prostate growth: evidence of androgeno-dependence.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Influence of age on serum prolactin levels in women and men

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Oncological complications of excess GH in acromegaly

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Transgenic Mice Overexpressing the Prolactin Gene Develop Dramatic Enlargement of the Prostate Gland1

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

Different biological effects of unmodified prolactin and a molecular mimic of phosphorylated prolactin involve different signaling pathways.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

The changing therapeutic landscape of castration-resistant prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-12114-7_10

10.1007/978-3-319-12114-7_10

31 March 2020

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25472541%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

1 reference